Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
INMB
$1.93
+0.00%
INMB
· Inmune Bio, Inc.
$1.93
+0.00 (+0.00%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 6, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events raise substantial doubt about the Company's ability to continue as a going concern. ... Because management's plans have not yet been finalized and are not within the Company's control, the implementation of such plans cannot be considered probable. As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 6, 2026
Market Cap
$56.34M
Shares
27.75M
Volume · Oct 2
290.24K
Avg daily vol (3M)
455.31K
All webcasts
Earnings call · FY2019 Q4
Inmune Bio, Inc. (INMB) Q4 2019 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Net income · derived Q4
-$2.32M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 12, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 11, 2020 · complete as-filed document